Sequential immunization induces strong and broad immunity against all four dengue virus serotypes

[1]  E. Moreira,et al.  Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial , 2020, The Lancet.

[2]  J. Jimeno,et al.  Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents. , 2019, The New England journal of medicine.

[3]  Marie Nguyen,et al.  The Ultimate qPCR Experiment: Producing Publication Quality, Reproducible Data the First Time. , 2019, Trends in biotechnology.

[4]  Jianzhu Chen,et al.  Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice , 2019, Front. Immunol..

[5]  Eiryo Kawakami,et al.  T Follicular Helper Cell‐Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate , 2018, Immunity.

[6]  M. Turchi,et al.  Dengue-specific serotype related to clinical severity during the 2012/2013 epidemic in centre of Brazil , 2017, Infectious Diseases of Poverty.

[7]  Mehran Kardar,et al.  Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens , 2016, Proceedings of the National Academy of Sciences.

[8]  K. Fink,et al.  Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool , 2016, EBioMedicine.

[9]  John P. Moore,et al.  Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C , 2016, PLoS pathogens.

[10]  Evgeny S. Egorov,et al.  High-quality full-length immunoglobulin profiling with unique molecular barcoding , 2016, Nature Protocols.

[11]  S. Ching,et al.  Meta-Analysis of Dengue Severity during Infection by Different Dengue Virus Serotypes in Primary and Secondary Infections , 2016, PloS one.

[12]  Y. Liu,et al.  Cyclophilin A as a potential genetic adjuvant to improve HIV-1 Gag DNA vaccine immunogenicity by eliciting broad and long-term Gag-specific cellular immunity in mice , 2016, Human vaccines & immunotherapeutics.

[13]  D. Fear,et al.  Transcription factors regulating B cell fate in the germinal centre , 2016, Clinical and experimental immunology.

[14]  Steven H. Kleinstein,et al.  Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data , 2015, Bioinform..

[15]  K. Basso,et al.  Germinal centres and B cell lymphomagenesis , 2015, Nature Reviews Immunology.

[16]  U. Klein,et al.  Dynamics of B cells in germinal centres , 2015, Nature Reviews Immunology.

[17]  Mehran Kardar,et al.  Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies , 2015, Cell.

[18]  G. Carrasquilla,et al.  Efficacy of a tetravalent dengue vaccine in children in Latin America. , 2015, The New England journal of medicine.

[19]  P. Milpied,et al.  Switched-memory B cells remodel B cell receptors within secondary germinal centers , 2015, Nature Immunology.

[20]  D. Gubler,et al.  Review article: Research on dengue during World War II revisited. , 2014, The American journal of tropical medicine and hygiene.

[21]  P. Pitisuttithum,et al.  Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial , 2014, The Lancet.

[22]  B. Guy,et al.  Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico , 2014, Human vaccines & immunotherapeutics.

[23]  David A. Hafler,et al.  pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires , 2014, Bioinform..

[24]  T. Panavas,et al.  IgG variable region and VH CDR3 diversity in unimmunized mice analyzed by massively parallel sequencing. , 2014, Molecular immunology.

[25]  Mario Roederer,et al.  Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine , 2013, Science.

[26]  T. Scott,et al.  Reduced risk of disease during postsecondary dengue virus infections. , 2013, The Journal of infectious diseases.

[27]  M. Gregory,et al.  Mechanism of somatic hypermutation at the WA motif by human DNA polymerase η , 2013, Proceedings of the National Academy of Sciences.

[28]  R. Kuhn.  Faculty Opinions recommendation of Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. , 2012 .

[29]  Saravudh Suvannadabba,et al.  Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial , 2012, The Lancet.

[30]  M. Nussenzweig,et al.  Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. , 2012, Blood.

[31]  Jin Hyang Kim,et al.  Strategies to alleviate original antigenic sin responses to influenza viruses , 2012, Proceedings of the National Academy of Sciences.

[32]  Steven H. Kleinstein,et al.  Quantifying selection in high-throughput Immunoglobulin sequencing data sets , 2012, Nucleic acids research.

[33]  K. Basso,et al.  Roles of BCL6 in normal and transformed germinal center B cells , 2012, Immunological reviews.

[34]  Subhash G. Vasudevan,et al.  Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection , 2011, Proceedings of the National Academy of Sciences.

[35]  N. Haigwood,et al.  Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies , 2011, Journal of Virology.

[36]  B. Murphy,et al.  Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic. , 2011, The Journal of infectious diseases.

[37]  Cameron P. Simmons,et al.  An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection , 2010, Journal of Virology.

[38]  J. Farrar,et al.  Clinical, epidemiological and virological features of dengue virus infections in vietnamese patients presenting to primary care facilities with acute undifferentiated fever , 2010, The Journal of infection.

[39]  A. Nisalak,et al.  Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance. , 2009, The American journal of tropical medicine and hygiene.

[40]  T. Tiller,et al.  Cloning and expression of murine Ig genes from single B cells. , 2009, Journal of immunological methods.

[41]  Bjoern Peters,et al.  A Protective Role for Dengue Virus-Specific CD8+ T Cells 1 , 2009, The Journal of Immunology.

[42]  K. Rajewsky,et al.  Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. , 2008, Immunity.

[43]  A. Barrett,et al.  Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. , 2008, Viral immunology.

[44]  G. Chang,et al.  Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II , 2008, Journal of Virology.

[45]  Richard G Jarman,et al.  Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. , 2007, The American journal of tropical medicine and hygiene.

[46]  J. Cyster,et al.  Germinal-center organization and cellular dynamics. , 2007, Immunity.

[47]  M. Neuberger,et al.  Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.

[48]  J. Low,et al.  Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. , 2006, Annals of the Academy of Medicine, Singapore.

[49]  Naoki Yamamoto,et al.  Sequential Immunization with V3 Peptides from Primary Human Immunodeficiency Virus Type 1 Produces Cross-Neutralizing Antibodies against Primary Isolates with a Matching Narrow-Neutralization Sequence Motif , 2006, Journal of Virology.

[50]  Y. Naumov,et al.  Memory of mice and men: CD8+ T‐cell cross‐reactivity and heterologous immunity , 2006, Immunological reviews.

[51]  L. Johnson,et al.  pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids. , 2006, Vaccine.

[52]  J. Harty,et al.  Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination , 2005, Nature Medicine.

[53]  F. Celada,et al.  CD8 memory T cells: cross-reactivity and heterologous immunity , 2004, Seminars in Immunology.

[54]  David L Woodland,et al.  Jump-starting the immune system: prime-boosting comes of age. , 2004, Trends in immunology.

[55]  A. Rothman,et al.  Dengue immune response: low affinity, high febrility , 2003, Nature Medicine.

[56]  K. Wright,et al.  Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines1 , 2003, The Journal of Immunology.

[57]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[58]  J. Altman,et al.  Evolution of the T Cell Repertoire During Primary, Memory, and Recall Responses to Viral Infection1 , 2000, The Journal of Immunology.

[59]  A S Perelson,et al.  Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts. , 1997, Journal of immunology.

[60]  A S Perelson,et al.  Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation. , 1993, Immunology today.

[61]  M. Stenzel-Poore,et al.  Immunologic memory to phosphocholine keyhole limpet hemocyanin. Recurrent mutations in the lambda 1 light chain increase affinity for antigen. , 1992, Journal of immunology.

[62]  C. Kocks,et al.  Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[64]  S. Halstead,et al.  Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic? , 1977, The Journal of tropical medicine and hygiene.

[65]  M. Hill.  Diversity and Evenness: A Unifying Notation and Its Consequences , 1973 .

[66]  R. Maul,et al.  AID and somatic hypermutation. , 2010, Advances in immunology.

[67]  H. Nishiura.  Duration of short-lived cross-protective immunity against a clinical attack of dengue: A preliminary estimate , 2008 .

[68]  S. Halstead,et al.  Neutralization and antibody-dependent enhancement of dengue viruses. , 2003, Advances in virus research.

[69]  A. Rothman.  Immunology and immunopathogenesis of dengue disease. , 2003, Advances in virus research.

[70]  J. Roehrig.  Antigenic structure of flavivirus proteins. , 2003, Advances in virus research.

[71]  S. Halstead,et al.  Original antigenic sin in dengue. , 1983, The American journal of tropical medicine and hygiene.

[72]  A. Sabin.  Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.